Changes in health-related quality of life following the diagnosis and treatment of patients with non-muscle-invasive bladder cancer (NMIBC) remain poorly understood. A new study suggests that diagnosis and treatment of NMIBC might affect mental health as well as sexual, urinary and bowel function.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The patients’ experience of a bladder cancer diagnosis: a systematic review of the qualitative evidence
Journal of Cancer Survivorship Open Access 17 February 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schmidt, S. et al. Quality of life in patients with non-muscle-invasive bladder cancer: one-year results of a multicentre prospective cohort study. Urol. Oncol. http://dx.doi.org/10.1016/j.urolonc.2014.09.012.
Fung, C. et al. Impact of bladder cancer on health related quality of life in 1,476 older Americans: a cross-sectional study. J. Urol. 192, 690–695 (2014).
Gontero, P. et al. The impact of intravesical gemcitabine and 1/3 dose Bacillus Calmette-Guerin instillation therapy on the quality of life in patients with nonmuscle invasive bladder cancer: results of a prospective, randomized, phase II trial. J. Urol. 190, 857–862 (2013).
Blazeby, J. M. et al. Validation and reliability testing of the EORTC QLQ-NMIBC24 questionnaire module to assess patient-reported outcomes in non-muscle-invasive bladder cancer. Eur. Urol. 66, 1148–1156 (2014).
US National Library of Medicine. ClinicalTrials.gov [online], (2014).
Zietman, A. L. et al. Organ conservation in invasive bladder cancer by transurethral resection, chemotherapy and radiation: results of a urodynamic and quality of life study on long-term survivors. J. Urol. 170, 1772–1776 (2003).
Efstathiou, J. A. et al. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur. Urol. 61, 705–711 (2012).
Weiss, C. et al. Management of superficial recurrences in an irradiated bladder after combined-modality organ-preserving therapy. Int. J. Radiat. Oncol. Biol. Phys. 70, 1502–1506 (2008).
Zietman, A. L. et al. Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder. Urology 58, 380–385 (2001).
Sapre, N., Anderson, P. & Foroudi, F. Management of local recurrences in the irradiated bladder: a systematic review. BJU Int. 110, S51–S57 (2012).
Acknowledgements
The authors express their appreciation to Drs William U. Shipley and Jason A. Efstathiou for critical reading of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Sanchez, A., Wszolek, M. Quality of life in patients with non-muscle-invasive bladder cancer. Nat Rev Urol 12, 186–188 (2015). https://doi.org/10.1038/nrurol.2015.12
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2015.12
This article is cited by
-
Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and Future Directions
Current Oncology Reports (2023)
-
Relationships among uncertainty, post-traumatic stress disorder symptoms, and quality of life in non-muscle-invasive bladder cancer survivors
Supportive Care in Cancer (2022)
-
The patients’ experience of a bladder cancer diagnosis: a systematic review of the qualitative evidence
Journal of Cancer Survivorship (2017)
